Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle
This article was originally published in The Gray Sheet
Executive SummaryMedtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.
You may also be interested in...
Bionic eye, MRI-safe pacemaker are among recent new product approvals.
Mela Sciences launches MelaFind melanoma detection device in the U.S. Medtronic launches CapSure Sense MRI SureScan pacing leads overseas. More product news.